Søren Danielsen Juhl

Søren Danielsen Juhl serves as a Senior Investment Associate at the Export and Investment Fund of Denmark since November 2022, focusing on life science investments and managing a portfolio that includes companies such as Freya Biosciences and Levitate Technology. Simultaneously, Søren holds multiple Board Observer roles at Draupnir Bio, SOLID Therapeutics, Dania Therapeutics, HHC Medical, and Stimuliver. Prior experience includes serving as a Technology Strategy Graduate at Ambu A/S, and roles as a Student Assistant at Aquaporin A/S and NIRAS, along with an internship in R&D Portfolio Management at Novo Nordisk. Educational qualifications encompass a Master's degree in Business Administration and Bio-entrepreneurship from Copenhagen Business School and a Master's degree in Biology and Biotechnology from the University of Copenhagen, complemented by a Bachelor's degree in Chemical and Biochemical Engineering from the Technical University of Denmark.